Sign in
4

Changes in Ownership

Verrica Pharmaceuticals Inc. Filed Acc 0001209191-23-043301

Chief Commercial Officer sold 38,262 shares at $4.83 ($184,805)

  • Chief Commercial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bonaccorso Joe Chief Commercial Officer 2023-07-21 Grant or award +100,000 101,000 D: show line 1 in the form
Bonaccorso Joe Chief Commercial Officer 2023-07-24 Sale −38,262 $4.83 $184,805 62,738 D: show line 2 in the form
Open-market sales · 38,262 sh · avg $4.83 · $184,805
Loading xslF345X05/doc4.xml…